Results 1-3 of 3 for data protection segment:8887111

Joint Oireachtas Committee on Health: Funding and Implementation of the National Cancer Strategy: Discussion (10 Apr 2024)

...who sponsor those trials do not come back. That is the first problem we have. The regulatory environment is under-resourced and under-professionalised, particularly in HSE-run hospitals. The data protection process is labyrinthine and contradictory. If multiple institutions are trying to collaborate on a clinical trial, multiple DPOs are giving multiple opinions requiring multiple...

Joint Oireachtas Committee on Health: Funding and Implementation of the National Cancer Strategy: Discussion (10 Apr 2024)

Professor M. John Kennedy: We have the national ethics committee which is functioning effectively. The HPRA has to be involved. You have to submit a data protection impact assessment on every clinical trial. Each section 38 hospital has its own data protection officer. Because it is one legal entity, the HSE has one data protection officer with, I believe, four part-time sub-officers who...

Joint Oireachtas Committee on Health: Funding and Implementation of the National Cancer Strategy: Discussion (10 Apr 2024)

Ms Averil Power: It was beset by many of the issues that are now on the data protection side. The national ethics committee has done excellent work and presented recently to Cancer Trials Ireland on how it changed all of that and put in place a proper streamlining and national framework. Perhaps the committee could look at the data protection side because I think that is where, as...